Use of Genomic Testing to Asses Risks and Benefits of Hormone Therapy – Garry Gordon, MD

This is a preview of Use of Genomic Testing to Asses Risks and Benefits of Hormone Therapy by Garry Gordon, MD at the 2007 Anti-Aging London Conference. Visit www.antiageingconference.com for the conference sponsor FREE A4M Newsletter at www.worldhealth.net. FREE full lectures at www.instatapes.com on DiGiVision, video and slides synced. Item #ACL-071W04Pt.2 Continued

One Response to “Use of Genomic Testing to Asses Risks and Benefits of Hormone Therapy – Garry Gordon, MD”

Leave a Reply

CommentLuv Enabled

This site uses KeywordLuv. Enter YourName@YourKeywords in the Name field to take advantage.

CLICK BELOW TO BUY SYTROPIN
Buy Growth Hormone/HGH Books
Powered by Yahoo! Answers